mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.4 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.4 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
AZD-7545 |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.4 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |